LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

Search

Day One Biopharmaceuticals Inc

Fechado

SetorSaúde

7.49 -1.58

Visão Geral

Variação de preço das ações

24h

Atual

Mín

7.43

Máximo

7.5

Indicadores-chave

By Trading Economics

Rendimento

5.7M

-30M

Vendas

3.1M

34M

Margem de lucro

-89.424

Funcionários

182

EBITDA

5.2M

-35M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+206.26% upside

Dividendos

By Dow Jones

Próximos Ganhos

29 de out. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

55M

738M

Abertura anterior

9.07

Fecho anterior

7.49

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bearish Evidence

Day One Biopharmaceuticals Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

29 de ago. de 2025, 18:43 UTC

Grandes Movimentos do Mercado

Privia Health Shares Advance on Outlook Bump From Medicare Savings

29 de ago. de 2025, 15:07 UTC

Aquisições, Fusões, Aquisições de Empresas

Strathcona Resources to Increase Minority Stake in MEG Energy, Vote Against Cenovus Buyout Plan

30 de ago. de 2025, 08:20 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Auto & Transport Roundup: Market Talk

29 de ago. de 2025, 20:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Auto & Transport Roundup: Market Talk

29 de ago. de 2025, 20:24 UTC

Ganhos

Earnings Season Highlights on Tariffs, Consumer Spending, and More -- Barrons.com

29 de ago. de 2025, 20:17 UTC

Ganhos

These Stocks Moved the Most Today: Alibaba, Marvell, Affirm, Nvidia, Dell, Autodesk, Ambarella, IREN, and More -- Barrons.com

29 de ago. de 2025, 19:18 UTC

Conversa de Mercado

Oil Futures End Week With Modest Gains -- Market Talk

29 de ago. de 2025, 18:59 UTC

Conversa de Mercado

U.S. Natural Gas Futures Post Weekly Gains -- Market Talk

29 de ago. de 2025, 18:36 UTC

Ganhos

These Were the Best & Worst S&P 500 Stocks in August -- Barrons.com

29 de ago. de 2025, 18:26 UTC

Ganhos

What the Stock Market Learned About Earnings and Consumers This Summer -- Barrons.com

29 de ago. de 2025, 17:48 UTC

Conversa de Mercado

U.S. Oil Rig Count Increases By 1 to 412 -- Market Talk

29 de ago. de 2025, 17:10 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Regulator Firing Clears Path for Union Pacific-Norfolk Southern Deal -- Market Talk

29 de ago. de 2025, 16:57 UTC

Ganhos

These Stocks Are Moving the Most Today: Alibaba, Marvell, Affirm, Nvidia, Dell, Autodesk, Ambarella, IREN, and More -- Barrons.com

29 de ago. de 2025, 16:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Celsius Stock Is Spiking After PepsiCo Increases Stake -- Barrons.com

29 de ago. de 2025, 16:28 UTC

Aquisições, Fusões, Aquisições de Empresas

BBVA: Adjustment Intended to Maintain Equivalent Economic Terms of Offer Following Dividend Payments by Sabadell

29 de ago. de 2025, 16:27 UTC

Aquisições, Fusões, Aquisições de Empresas

BBVA: Adjustment Outlined in Announcement on May 9, 2024

29 de ago. de 2025, 16:26 UTC

Aquisições, Fusões, Aquisições de Empresas

BBVA Now Offering 1 Newly Issued Ordinary BBVA Share and EUR0.70 in Cash for Every 5.5483 Ordinary Shares of Sabadell

29 de ago. de 2025, 16:25 UTC

Aquisições, Fusões, Aquisições de Empresas

BBVA: Adjustment Factors in Interim Dividend Paid by Sabadell to Its Shareholders

29 de ago. de 2025, 16:24 UTC

Aquisições, Fusões, Aquisições de Empresas

BBVA Adjusts Offer for Banco de Sabadell

29 de ago. de 2025, 16:23 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Strathcona's Power Play in MEG Energy Jeopardizes Cenovus Deal -- Market Talk

29 de ago. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

29 de ago. de 2025, 16:06 UTC

Conversa de Mercado

Gold Futures Gain as U.S. Inflation Data Boost Rate Cut Hopes -- Market Talk

29 de ago. de 2025, 15:12 UTC

Conversa de Mercado
Ganhos

Best Buy Surprise Comp Growth Potentially Driven by Switch 2 -- Market Talk

29 de ago. de 2025, 15:09 UTC

Ganhos

Small-Cap Stocks Are Rallying Again. This Time It's Real. -- Barrons.com

29 de ago. de 2025, 15:01 UTC

Conversa de Mercado

Canadian Economy Expected to Slow But Grow in 2H -- Market Talk

29 de ago. de 2025, 14:49 UTC

Ganhos

These Stocks Are Moving the Most Today: Marvell, Dell, Nvidia, Alibaba, Affirm, Autodesk, Ambarella, IREN, and More -- Barrons.com

29 de ago. de 2025, 14:49 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

29 de ago. de 2025, 14:49 UTC

Conversa de Mercado

Canada May Avoid Contraction in 3Q, But Is Expected to Struggle -- Market Talk

29 de ago. de 2025, 14:48 UTC

Ganhos

Marvell Stock Tumbles. Why the AI Chip Player Keeps Disappointing the Market. -- Barrons.com

29 de ago. de 2025, 14:43 UTC

Conversa de Mercado

Rise in Canadian Household Spending May Not Worry Central Bank -- Market Talk

Comparação entre Pares

Variação de preço

Day One Biopharmaceuticals Inc Previsão

Preço-alvo

By TipRanks

206.26% parte superior

Previsão para 12 meses

Média 23 USD  206.26%

Máximo 34 USD

Mínimo 16 USD

Com base em 9 analistas de Wall Street que oferecem metas de preço de 12 meses para Day One Biopharmaceuticals Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

9 ratings

8

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

6.26 / 7.47Suporte e Resistência

Curto Prazo

Very Strong Bearish Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

Bearish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.